MCRB - Seres Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MCRB is currently covered by 3 analysts with an average price target of $112.78. This is a potential upside of $97.33 (629.97%) from yesterday's end of day stock price of $15.45.

Seres Therapeutics's activity chart (see below) currently has 58 price targets and 54 ratings on display. The stock rating distribution of MCRB is 25% SELL, 50% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.21% with an average time for these price targets to be met of 90.64 days.

Highest price target for MCRB is $22, Lowest price target is $6, average price target is $14.33.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 24-Sep-2025. First documented stock forecast 22-Oct-2015.

Currently out of the existing stock ratings of MCRB, 1 are a SELL (25%), 2 are a BUY (50%), 1 are a HOLD (25%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 10-Aug-2020

$22

$6.85 (45.21%)

3 months 15 days ago
(24-Sep-2025)

1/3 (33.33%)

$2.61 (13.46%)

55

Hold

Since 08-May-2025

$6

$-9.15 (-60.40%)

$25

8 months ago
(08-May-2025)

3/5 (60%)

$-0.96 (-13.79%)

249

Sell

Since 03-Nov-2023

$15

$-0.15 (-0.99%)

$25

9 months 25 days ago
(14-Mar-2025)

5/5 (100%)

$1.2 (8.70%)

81

Sell

Since 24-Oct-2024

$140

1 years 2 months 15 days ago
(24-Oct-2024)

0/1 (0%)

$11.2 (8.70%)

Buy

Since 25-Jan-2016

$240

$224.85 (1484.16%)

$720

2 years 6 months 13 days ago
(26-Jun-2023)

4/8 (50%)

$132 (122.22%)

281

Show more analysts

Please expand the browser size to see the chart

What is MCRB (Seres Therapeutics) average time for price targets to be met?

On average it took 90.64 days on average for the stock forecasts to be realized with a an average price target met ratio 51.21

Which analyst has the current highest performing score on MCRB (Seres Therapeutics) with a proven track record?

TAYLOR FEEHLEY

Which analyst has the most public recommendations on MCRB (Seres Therapeutics)?

Taylor Feehley has 1 price targets and 2 ratings on MCRB

Which analyst is the currently most bullish on MCRB (Seres Therapeutics)?

Gbola Amusa with highest potential upside - $584.85

Which analyst is the currently most reserved on MCRB (Seres Therapeutics)?

Keay Nakae with lowest potential downside - -$9.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?